Congratulations to Michael D. Dake and his whole team for winning the CVIR award for “Most Cited Article: Scientific Paper" in 2020. 🎉 Join the virtual award reception (Sept. 21, 14:00-15:00 CEST): https://t.co/XDKcrlqgAT Winning article: https://t.co/lIR9
RT @ETF_IRtrainees: Drug-eluting stents positioned for peripheral artery diseases do not result in increased long term mortality compared t…
Drug-eluting stents positioned for peripheral artery diseases do not result in increased long term mortality compared to uncoated devices https://t.co/HG2KDaBAkr https://t.co/FmxlSYS1Cc
Throwback Thursday: Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices | https://t.co/lIR9KS1ATa #Paclitaxel #Drugelutingstent #Irad https://t.co/xmUbmvWmqR
Jan Editors Choice Nr 2: Zilver PTX study act III: No difference in all-cause 5-year mortality for the DES compared to PTA/BMS after considering the cross over cases that received DES & the 3-year all-cause mortality in the post market study: https://t
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
Little food for thought amidst Paclitaxel gate. https://t.co/YxQbuBnSTp
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices. Read the study. https://t.co/pcFlsJIki6 #paclitaxel
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices. Read the study. https://t.co/pcFlsJIki6 #paclitaxel
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
RT @cookvascular: Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality comp…
An important addition to the paclitaxel and mortality conversation. Interested to hear the critical feedback from the experts: https://t.co/pHIwBAZwDo
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices. Read the study. https://t.co/pcFlsJqITw #paclitaxel
RT @CVIR_Journal: 📢📢Full articles on the first data release presented by Michael Dake & Konstantinos Donas at the FIRST@CIRSE session are n…
RT @CVIR_Journal: 📢📢Full articles on the first data release presented by Michael Dake & Konstantinos Donas at the FIRST@CIRSE session are n…
📢📢Full articles on the first data release presented by Michael Dake & Konstantinos Donas at the FIRST@CIRSE session are now available to read in CVIR online: Donas: https://t.co/V7o4rRymAF Dake: https://t.co/lIR9KS1ATa #CIRSE2019 https://t.co/w2hN0P
“Analyses of the PTX patient-level data demonstrated no increase in long-term all-cause mortality.” https://t.co/rpRp5IMN6o